Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Medipharm Labs Corp (OP:MEDIF)

0.0458 -0.0038 (-7.66%)
Streaming Delayed Price Updated: 2:42 PM EST, Dec 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,387
Open 0.0488
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0496
Today's Range 0.0451 - 0.0520
52wk Range 0.0379 - 0.0850
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
From MediPharm Labs Corp.
Via GlobeNewswire

Performance

YTD
+7.5%
+7.5%
1 Month
-12.8%
-12.8%
3 Month
-16.4%
-16.4%
6 Month
-15.0%
-15.0%
1 Year
-4.4%
-4.4%

More News

Read More
News headline image
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
Apollo Capital Wins Proxy Contest at MediPharm Labs
From Apollo Technology Capital Corporation
Via GlobeNewswire
News headline image
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company
From Apollo Technology Capital Corporation
Via GlobeNewswire
News headline image
This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago ↗
Via Benzinga
Topics Cannabis
News headline image
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
News headline image
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
Alleged Securities Fraud at MediPharm Labs Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
News headline image
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma
From Apollo Technology Capital Corporation
Via GlobeNewswire
News headline image
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
From MediPharm Labs Corp.
Via GlobeNewswire
News headline image
Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting
From Apollo Technology Capital Corporation
Via GlobeNewswire
News headline image
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
From MediPharm Labs Corp.
Via GlobeNewswire

Frequently Asked Questions

Is Medipharm Labs Corp publicly traded?
Yes, Medipharm Labs Corp is publicly traded.
What exchange does Medipharm Labs Corp trade on?
Medipharm Labs Corp trades on the OTC Traded
What is the ticker symbol for Medipharm Labs Corp?
The ticker symbol for Medipharm Labs Corp is MEDIF on the OTC Traded
What is the current price of Medipharm Labs Corp?
The current price of Medipharm Labs Corp is 0.0458
When was Medipharm Labs Corp last traded?
The last trade of Medipharm Labs Corp was at 12/03/25 02:42 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.